BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24845791)

  • 21. Myxoma virus derived immune modulating proteins, M-T7 and Serp-1, reduce early inflammation after spinal cord injury in the rat model.
    Kwiecien JM; Dabrowski W; Marzec-Kotarska B; Kwiecien-Delaney CJ; Yaron JR; Zhang L; Schutz L; Lucas AR
    Folia Neuropathol; 2019; 57(1):41-50. PubMed ID: 31038187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory specificity of the anti-inflammatory myxoma virus serpin, SERP-1.
    Nash P; Whitty A; Handwerker J; Macen J; McFadden G
    J Biol Chem; 1998 Aug; 273(33):20982-91. PubMed ID: 9694848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serpins: Development for Therapeutic Applications.
    Lucas A; Yaron JR; Zhang L; Macaulay C; McFadden G
    Methods Mol Biol; 2018; 1826():255-265. PubMed ID: 30194606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral serpin therapeutics from concept to clinic.
    Chen H; Zheng D; Davids J; Bartee MY; Dai E; Liu L; Petrov L; Macaulay C; Thoburn R; Sobel E; Moyer R; McFadden G; Lucas A
    Methods Enzymol; 2011; 499():301-29. PubMed ID: 21683260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myxomavirus serpin alters macrophage function and prevents diffuse alveolar hemorrhage in pristane-induced lupus.
    Zhuang H; Han S; Lu L; Reeves WH
    Clin Immunol; 2021 Aug; 229():108764. PubMed ID: 34089860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infection.
    Chen H; Zheng D; Abbott J; Liu L; Bartee MY; Long M; Davids J; Williams J; Feldmann H; Strong J; Grau KR; Tibbetts S; Macaulay C; McFadden G; Thoburn R; Lomas DA; Spinale FG; Virgin HW; Lucas A
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4114-27. PubMed ID: 23774438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cowpox virus SPI-3 and myxoma virus SERP1 serpins are not functionally interchangeable despite their similar proteinase inhibition profiles in vitro.
    Wang YX; Turner PC; Ness TL; Moon KB; Schoeb TR; Moyer RW
    Virology; 2000 Jul; 272(2):281-92. PubMed ID: 10873771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human leukocyte proteinase 3 by a novel recombinant serine proteinase inhibitor (LEX032).
    Groutas WC; Ruan S; Kuang R; Hook JB; Sands H
    Biochem Biophys Res Commun; 1997 Apr; 233(3):697-9. PubMed ID: 9168917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of Manduca sexta serpin-6: a serine proteinase inhibitor that selectively inhibits prophenoloxidase-activating proteinase-3.
    Wang Y; Jiang H
    Insect Biochem Mol Biol; 2004 Apr; 34(4):387-95. PubMed ID: 15041022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
    Tardif JC; L'Allier PL; Grégoire J; Ibrahim R; McFadden G; Kostuk W; Knudtson M; Labinaz M; Waksman R; Pepine CJ; Macaulay C; Guertin MC; Lucas A
    Circ Cardiovasc Interv; 2010 Dec; 3(6):543-8. PubMed ID: 21062996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunosuppressive functions of two novel tick serpins, HlSerpin-a and HlSerpin-b, from Haemaphysalis longicornis.
    Wang F; Song Z; Chen J; Wu Q; Zhou X; Ni X; Dai J
    Immunology; 2020 Jan; 159(1):109-120. PubMed ID: 31606893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin alters viral serpin, serp-1, anti-thrombolytic activity to anti-thrombotic activity.
    Li X; Schneider H; Peters A; Macaulay C; King E; Sun Y; Liu L; Dai E; Davids JA; McFadden G; Lucas A
    Open Biochem J; 2008; 2():6-15. PubMed ID: 18949070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis.
    Charles-Schoeman C; Banquerigo ML; Hama S; Navab M; Park GS; Van Lenten BJ; Wagner AC; Fogelman AM; Brahn E
    Clin Immunol; 2008 May; 127(2):234-44. PubMed ID: 18337176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The suppressive effects of Saposhnikovia divaricata (Fangfeng) chromone extract on rheumatoid arthritis via inhibition of nuclear factor-κB and mitogen activated proteinkinases activation on collagen-induced arthritis model.
    Kong X; Liu C; Zhang C; Zhao J; Wang J; Wan H; Zhu H; Zhang P; Chen W; Xiao Y; Lin N
    J Ethnopharmacol; 2013 Jul; 148(3):842-50. PubMed ID: 23711830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
    Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
    Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serpins for diagnosis and therapy in cancer.
    Zheng D; Chen H; Davids J; Bryant M; Lucas A
    Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):123-32. PubMed ID: 23988000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressive effect of a neutrophil elastase inhibitor on the development of collagen-induced arthritis.
    Kakimoto K; Matsukawa A; Yoshinaga M; Nakamura H
    Cell Immunol; 1995 Oct; 165(1):26-32. PubMed ID: 7671322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
    Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
    J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.